West Pharmaceutical Services (WST) Accounts Payables (2009 - 2026)

West Pharmaceutical Services' Accounts Payables history runs 18 years deep, the most recent figure standing at $252.3 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 10.46% year-over-year to $252.3 million; the TTM figure through Mar 2026 stood at $252.3 million (up 10.46% YoY), while the FY2025 annual figure was $253.7 million, up 6.02% from the prior year.
• Accounts Payables came in at $252.3 million for Q1 2026 at West Pharmaceutical Services, down from $253.7 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $255.8 million in Q3 2025 to a low of $188.9 million in Q3 2022.
• A 5-year average of $231.2 million and a median of $233.8 million in 2023 frame the typical range for Accounts Payables.
• On a YoY basis, Accounts Payables climbed as much as 21.49% in 2022 and fell as far as 9.05% in 2022.
• West Pharmaceutical Services' Accounts Payables stood at $215.4 million in 2022, then climbed by 12.53% to $242.4 million in 2023, then declined by 1.28% to $239.3 million in 2024, then gained by 6.02% to $253.7 million in 2025, then fell by 0.55% to $252.3 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $252.3 million, $253.7 million, and $255.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison